e-learning
resources
Barcelona 2010
Monday, 20.09.2010
Biomarkers for lung cancer
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Diagnostic markers of lung cancer in bronquial fluid: Development of inmunoassays and validation
S. Pedrero, N. Marina, A. Gomez, B. Ruiz-Argüello, M. Uribarri, J. Algorta, S. Carrera, G. López Vivanco, R. Zalacain (Barakaldo, Zamudio, Spain)
Source:
Annual Congress 2010 - Biomarkers for lung cancer
Session:
Biomarkers for lung cancer
Session type:
Thematic Poster Session
Number:
3239
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Pedrero, N. Marina, A. Gomez, B. Ruiz-Argüello, M. Uribarri, J. Algorta, S. Carrera, G. López Vivanco, R. Zalacain (Barakaldo, Zamudio, Spain). Diagnostic markers of lung cancer in bronquial fluid: Development of inmunoassays and validation. Eur Respir J 2010; 36: Suppl. 54, 3239
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
Validation of diagnostic molecular markers in bronchial fluid for lung cancer
Source: Annual Congress 2011 - Progress in endoscopy for the diagnosis of lung cancer
Year: 2011
Potential lung cancer biomarkers from bronchoalveolar lavage fluid using metabolomics approaches
Source: International Congress 2016 – Prognostic variables in lung cancer I
Year: 2016
Diagnostic value of bronchoscopic methods in lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 514s
Year: 2006
Diagnostic utility of cell block method combined with conventional smear cytology in the diagnosis of exudative pleural effusions accompanying lung cancer
Source: Annual Congress 2013 –Diagnosis and management of pleural and mediastinal diseases
Year: 2013
mRNA biomarker screening in pulmonary tumors showing neuroendocrine differentiation
Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer
Year: 2013
Serum and bronchial aspiration fluid HE-4 levels in lung cancer
Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers
Year: 2015
The utility of survivin mRNA as a diagnostic biomarker in lung cancer with malignant pleural effusion
Source: Annual Congress 2013 –Fundamental biology of malignant pleural effusions
Year: 2013
Detection of EpCAM-positive microparticles in pleural fluid: A new approach for the diagnosis of the tumoral origin of pleural effusions
Source: International Congress 2015 – Emerging technologies for malignant pleural diseases management
Year: 2015
Prognostic validation of cryobiopsy for the diagnosis of interstitial lung diseases
Source: International Congress 2019 – Transbronchial cryobiopsy and endobronchial ultrasound
Year: 2019
Potential genetic markers for the early diagnosis of peripheral and metastatic lung cancer
Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers
Year: 2015
Potential diagnostic markers in bronquial fluid of patients with non small cell lung cancer (NSCLC)
Source: Annual Congress 2009 - Biological and clinical markers in lung cancer
Year: 2009
Serum IL-33 as a diagnostic and prognostic marker in non- small cell lung cancer
Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours
Year: 2014
Comparison analysis of malignant and tuberculous pleural fluid using proteomic method
Source: International Congress 2016 – Mesothelioma and malignant pleural disease
Year: 2016
Dividing EBUS-TBNA samples for simultaneous histopathological and molecular analyses in lung cancer patients
Source: International Congress 2015 – Endoscopic ultrasound: an essential tool for interventional pulmonology
Year: 2015
Utility of Immunohistochemical markers on EBUS TBNA samples in Specific Diagnostic Subtyping and multiple gene analyses in Primary and Metastatic Lung Cancer – Indian Study
Source: International Congress 2019 – Interventional pulmonology: endobronchial ultrasound-transbronchial needle aspiration
Year: 2019
The utility of bronchoscopically acquired tissue for successful lung cancer molecular profiling (LC-MP)
Source: Annual Congress 2013 –Comfort, safety and effectiveness of bronchoscopy
Year: 2013
Assessment of
SHOX2
methylation in EBUS-TBNA specimen improves accuracy in lung cancer staging
Source: Annual Congress 2013 –New frontiers for EBUS-TBNA: the mediastinum and beyond
Year: 2013
Bronchoscopic semantics and diagnosis of lung cancer
Source: Annual Congress 2013 –Progress in bronchoscopy and pathology techniques for diagnosis of thoracic malignancies
Year: 2013
Diagnostic value of tumor markers and cells population in bronchoalveolar lavage in lung cancer
Source: Eur Respir J 2003; 22: Suppl. 45, 37s
Year: 2003
Prevalence of preinvasive bronchial lesions in patients with lung cancer
Source: Annual Congress 2013 –Progress in bronchoscopy and pathology techniques for diagnosis of thoracic malignancies
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept